Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

A Five Fold Decrease in Admissions for Uncomplicated Vaso-Occlusive Crisis and Other Benefits from Care in Infusion Clinics: Results from the Escaped Trial

Blood (2018) 132 (Supplement 1): 853.

https://doi.org/10.1182/blood-2018-99-111484

Published: 2018

Journal Articles

Patient Satisfaction of Care in the Treatment of Vaso-Occlusive Crises: A Comparison of Emergency Department and Infusion Centers in the Escaped Study

Blood (2018) 132 (Supplement 1): 314.

https://doi.org/10.1182/blood-2018-99-111544

Published: 2018

Journal Articles

Men with Sickle Cell Disease Show Significant Concerns over Safety While Being Treated for Vaso-Occlusive Crises: Preliminary Observations from the Escaped Trial

Blood (2017) 130 (Supplement 1): 129.

https://doi.org/10.1182/blood.V130.Suppl_1.129.129

Published: 2017

Journal Articles

Acute Care Utilization Is More Common in Patients with Sickle Cell Disease Who Have Chronic Complications and Chronic Pain: A Preliminary Report from the Escaped Trial

Sophie Lanzkron, MD MHS, Carlton Haywood, Jr., PhD MA, Jane A Little, MD, Joshua Field, MD MS, Joseph Ryan Shows, MD, Jodi Segal, MD MPH, Mustapha Saheed, MD, Derek Robertson, JD, MBA, Marc V Proudford, MBA, MS, Adrienne Kincaid, Lorri Burgess, Charles Green, Hang Wang, PhD, Rebecca Seufert, BS, Jasmine Brooks, BA, Brandi Griffin, BSN, RN, Allie Piehet, BS, Steven Frymark, BA, Ravi Varadhan, PhD

Blood (2016) 128 (22): 2490.

https://doi.org/10.1182/blood.V128.22.2490.2490

Published: 2016

Journal Articles

Metabolic Syndrome Risk Among Adults Living with Sickle Cell Disease

Shawn M Bediako, PhD, Julie Nelson, BS, Cody Cichowitz, BS, Tiffany Yu, BS, C. Patrick Carroll, MD, Kerry J. Stewart, Ed.D., Rakhi P. Naik, MD MHS, Carlton Haywood, Jr., PhD MA, Sophie Lanzkron, MD MHS

Blood (2015) 126 (23): 3405.

https://doi.org/10.1182/blood.V126.23.3405.3405

Published: 2015

Journal Articles

Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization By Patients with Sickle Cell Disease

Tiffany Yu, Timothy Campbell, Isabella Ciuffetelli, Carlton Haywood, PhD MA, Christopher Patrick Carroll, MD, Linda M. S. Resar, MD, John J. Strouse, MD PhD, Sophie Lanzkron, MD MHS

Blood (2014) 124 (21): 2709.

https://doi.org/10.1182/blood.V124.21.2709.2709

Published: 2014

Journal Articles

Screening for Neurocognitive Dysfunction in an Adult Population with Sickle Cell Disease

Cody Cichowitz, MDcal Student, C. Patrick Carroll, MD, John J. Strouse, MD PhD, Carlton Haywood, PhD MA, Sophie Lanzkron, MD MHS

Blood (2014) 124 (21): 2717.

https://doi.org/10.1182/blood.V124.21.2717.2717

Published: 2014

Journal Articles

Venous Thromboembolism Incidence In The Cooperative Study Of Sickle Cell Disease: The Untold Story

Rakhi P. Naik, MD, Carlton Haywood, Jr., PhD, MA, Michael B. Streiff, MD, Sophie Lanzkron, MD, MHS

Blood (2013) 122 (21): 2214.

https://doi.org/10.1182/blood.V122.21.2214.2214

Published: 2013

Journal Articles

Perceived Discrimination In Health Care Is Associated With Daily Chronic Pain In Sickle Cell Disease

Carlton Haywood, Jr., PhD, MA, Sophie Lanzkron, MD, MHS, C. Patrick Carroll, MD, John J. Strouse, MD, PhD, Shawn M Bediako, PhD, Jennifer Haythornthwaite, PhD, Gladys T Onojobi, MD, Mary Catherine Beach, MD, MPH

Blood (2013) 122 (21): 5577.

https://doi.org/10.1182/blood.V122.21.5577.5577

Published: 2013

Journal Articles

NIH and National Foundation Expenditures For Sickle Cell Disease and Cystic Fibrosis Are Associated With Pubmed Publications and FDA Approvals

John J. Strouse, MD, PhD, Katie Lobner, MLIS, Sophie Lanzkron, MD, MHS, Carlton Haywood, Jr., PhD, MA

Blood (2013) 122 (21): 1739.

https://doi.org/10.1182/blood.V122.21.1739.1739

Published: 2013

Journal Articles

Describing Adherence to Recommended Preventative Care Behaviors Among Adults with Sickle Cell Disease

Sophie Lanzkron, MD, MHS, Carlton Haywood, Jr., PhD, MA, Gladys T Onojobi, MD, John J. Strouse, MD, PhD, Mary Catherine Beach, MD, MPH

Blood (2012) 120 (21): 2058.

https://doi.org/10.1182/blood.V120.21.2058.2058

Published: 2012

Journal Articles

Trends In the Hospital Treatment of Sickle Cell Disease-Related Priapism In the United States: 1998 to 2007,

Onaopemipo B. Ajiboye, MD, MPH, Sophie Lanzkron, MD, MHS, Mary Catherine Beach, MD, MPH, Shawn M Bediako, PhD, Arthur L. Burnett, M.D., M.B.A., Carlton Haywood, Jr., PhD, MA

Blood (2011) 118 (21): 4195.

https://doi.org/10.1182/blood.V118.21.4195.4195

Published: 2011

Journal Articles

Do Sickle Cell Patients Wait Longer to See Physicians in the Emergency Department?

Carlton Haywood, Jr., PhD, MA, Rakhi Naik, MD, Mary Catherine Beach, MD, MPH, Sophie Lanzkron, MD, MHS

Blood (2011) 118 (21): 2070.

https://doi.org/10.1182/blood.V118.21.2070.2070

Published: 2011

Journal Articles

Trends In Mortality Rates and Age of Death In Sickle Cell Disease (SCD): 1979–2005

Sophie Lanzkron, MD, MHS, Carlton Haywood, MA, PhD

Blood (2010) 116 (21): 736.

https://doi.org/10.1182/blood.V116.21.736.736

Published: 2010

Journal Articles

The First National Level Estimate of Emergency Department Charges for Sickle Cell Disease.

Sophie Lanzkron, MD, Carlton Haywood, Jr., PhD, MA

Blood (2009) 114 (22): 553.

https://doi.org/10.1182/blood.V114.22.553.553

Published: 2009

Journal Articles

The Burden of Hospital Readmissions for Patients with Sickle Cell Disease in California and North Carolina: 2004 to 2007.

Carlton Haywood, Jr., PhD, MA, Sophie Lanzkron, MD

Blood (2009) 114 (22): 554.

https://doi.org/10.1182/blood.V114.22.554.554

Published: 2009

Journal Articles

Sickle Cell Disease Mortality in the United States: Age at Death and Contributing Causes.

Carlton Haywood, Jr., MA, Sophie Lanzkron, MD

Blood (2007) 110 (11): 81.

https://doi.org/10.1182/blood.V110.11.81.81

Published: 2007

Journal Articles

Documenting the Effectiveness of Hydroxyurea (HU) To Treat Sickle Cell Disease (SCD) in the Community Setting.

Sophie Lanzkron, MD, Carlton Haywood, Jr., MA, Peter Fagan, MD

Blood (2007) 110 (11): 956.

https://doi.org/10.1182/blood.V110.11.956.956

Published: 2007

Journal Articles

Predictors of In-Hospital Mortality and Charges in Sickle Cell Disease: Results from the California Discharge Databases 1998–2005.

John J. Strouse, MD, Carlton Haywood, MA, Sophie Lanzkron, MD

Blood (2007) 110 (11): 432.

https://doi.org/10.1182/blood.V110.11.432.432

Published: 2007

Journal Articles

Gender and Regional Differences in In-Hospital Mortality in Patients with Sickle Cell Anemia (SCA) in the United States: Results from the Nationwide Inpatient Sample (NIS) 1993-2003.

Carlton Haywood, Jr., MA, Sophie Lanzkron, MD

Blood (2006) 108 (11): 461.

https://doi.org/10.1182/blood.V108.11.461.461

Published: 2006

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

A Five Fold Decrease in Admissions for Uncomplicated Vaso-Occlusive Crisis and Other Benefits from Care in Infusion Clinics: Results from the Escaped Trial

Patient Satisfaction of Care in the Treatment of Vaso-Occlusive Crises: A Comparison of Emergency Department and Infusion Centers in the Escaped Study

Men with Sickle Cell Disease Show Significant Concerns over Safety While Being Treated for Vaso-Occlusive Crises: Preliminary Observations from the Escaped Trial

Acute Care Utilization Is More Common in Patients with Sickle Cell Disease Who Have Chronic Complications and Chronic Pain: A Preliminary Report from the Escaped Trial

Metabolic Syndrome Risk Among Adults Living with Sickle Cell Disease

Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization By Patients with Sickle Cell Disease

Screening for Neurocognitive Dysfunction in an Adult Population with Sickle Cell Disease

Venous Thromboembolism Incidence In The Cooperative Study Of Sickle Cell Disease: The Untold Story

Perceived Discrimination In Health Care Is Associated With Daily Chronic Pain In Sickle Cell Disease

NIH and National Foundation Expenditures For Sickle Cell Disease and Cystic Fibrosis Are Associated With Pubmed Publications and FDA Approvals

Describing Adherence to Recommended Preventative Care Behaviors Among Adults with Sickle Cell Disease

Trends In the Hospital Treatment of Sickle Cell Disease-Related Priapism In the United States: 1998 to 2007,

Do Sickle Cell Patients Wait Longer to See Physicians in the Emergency Department?

Trends In Mortality Rates and Age of Death In Sickle Cell Disease (SCD): 1979–2005

The First National Level Estimate of Emergency Department Charges for Sickle Cell Disease.

The Burden of Hospital Readmissions for Patients with Sickle Cell Disease in California and North Carolina: 2004 to 2007.

Sickle Cell Disease Mortality in the United States: Age at Death and Contributing Causes.

Documenting the Effectiveness of Hydroxyurea (HU) To Treat Sickle Cell Disease (SCD) in the Community Setting.

Predictors of In-Hospital Mortality and Charges in Sickle Cell Disease: Results from the California Discharge Databases 1998–2005.

Gender and Regional Differences in In-Hospital Mortality in Patients with Sickle Cell Anemia (SCA) in the United States: Results from the Nationwide Inpatient Sample (NIS) 1993-2003.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only